DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Sciascia S, Radin M, Cecchi I. et al.
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol.
Clin Exp Rheumatol 2022;
DOI: 10.55563/clinexprheumatol/qa2yb4.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.